- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.07. | Modular Medical forms advisory council for Pivot insulin pump | 3 | Investing.com | ||
| 23.07. | Modular Medical, Inc.: Modular Medical Announces Formation of Pivot Innovation Council and Appointment of Robert Gabbay, MD, PhD, FACP as Chairman | 262 | ACCESS Newswire | - Council to Provide Strategic Clinical Guidance on Commercialization, Patient Identification, Workflow Integration, and Evidence Generation SAN DIEGO, CA / ACCESS Newswire / July 23, 2026 / Modular... ► Artikel lesen | |
| MODULAR MEDICAL Aktie jetzt für 0€ handeln | |||||
| 17.07. | Modular Medical inks IMO Health collab for insulin pump EHR integration | 2 | MassDevice | ||
| 16.07. | Modular Medical partners with IMO Health on patient identification tool | 5 | Investing.com | ||
| 16.07. | Modular Medical und IMO Health entwickeln Algorithmus zur Identifizierung von Diabetespatienten | 2 | Investing.com Deutsch | ||
| 16.07. | Modular Medical, Inc.: Modular Medical and IMO Health Launch Strategic Pilot to Enable Real Time Insulin Pump Patient Identification Into Electronic Health Records | 293 | ACCESS Newswire | Pilot Combines Clinician Guided Phenotypes with IMO Health's Unique Terminology Identifiers to Help Clinicians Easily Identify Patients Most Likely to Benefit from Pivot Insulin Pump TherapyAdvancing... ► Artikel lesen | |
| 15.07. | Modular Medical, Inc.: Modular Medical Receives Research Demonstrating Positive Payor Reception of Pivot Tubeless Patch Pump | 207 | ACCESS Newswire | Completed Independent Study Strongly Supports Favorable Payor Receptivity to Pivot's Differentiated Design and Simplified User Experience, and provides further validation of significant progress towards... ► Artikel lesen | |
| 14.07. | Modular Medical, Inc.: Modular Medical Announces Completion of Research Initiative Indicating Strong Interest in Simpler Insulin Delivery | 319 | ACCESS Newswire | 97% of Surveyed Injection Users Would Consider Pump Therapy - if Easier to Learn and Improved OutcomesConducting Additional Research Initiative in Conjunction with Commercialization of the Pivot Tubeless... ► Artikel lesen | |
| 01.07. | Modular Medical reicht Software-Verbesserungen für Pivot-System bei FDA ein | 2 | Investing.com Deutsch | ||
| 01.07. | Modular Medical, Inc.: Modular Medical Announces FDA Submission of Pivot Tubeless Insulin Patch Pump Enhancements | 270 | ACCESS Newswire | Submission Covers Software Enhancements for Patient Flexibility and Customization of Pivot SAN DIEGO, CA / ACCESS Newswire / July 1, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company")... ► Artikel lesen | |
| 30.06. | Modular Medical startet kommerzielle Einführung seiner Insulinpumpe | 5 | Investing.com Deutsch | ||
| 30.06. | Modular Medical begins commercial insulin pump deployment | 2 | Investing.com | ||
| 30.06. | Modular Medical, Inc.: Modular Medical Delivers Insulin to First Patients on Pivot Tubeless Insulin Patch Pump | 387 | ACCESS Newswire | First Patients Began Device Training and Insulin Delivery Today, Marking Transition to a Commercial CompanyPivot is the First Insulin Pump Designed to Address the Large, Underserved Population of Insulin-Dependent... ► Artikel lesen | |
| 30.06. | EXCLUSIVE: Modular Medical Advances Commercial Rollout With First Active Users Of Pivot Insulin Pump | 2 | Benzinga.com | ||
| 29.06. | Modular Medical, Inc. - 10-K, Annual Report | 5 | SEC Filings | ||
| 26.06. | Modular Medical begins shipping Pivot insulin pump to doctors | 1 | Investing.com | ||
| 26.06. | Modular Medical, Inc.: Modular Medical Announces Shipment of Pivot Tubeless Patch Pumps | 285 | ACCESS Newswire | Pivot starter kits are now shipping to multiple endocrinology practices SAN DIEGO, CA / ACCESS Newswire / June 26, 2026 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), a... ► Artikel lesen | |
| 24.06. | Modular Medical launches Pivot tubeless insulin patch pump | 1 | MassDevice | ||
| 24.06. | Modular Medical, Inc.: Modular Medical Announces Commercial Availability of Pivot Tubeless Insulin Patch Pump Ahead of Commercial Expansion | 412 | ACCESS Newswire | The Pivot tubeless insulin patch pump is now commercially available in the U.S. following FDA 510(k) clearance in AprilPivot represents a differentiated solution for insulin-dependent adults still on... ► Artikel lesen | |
| 24.06. | EXCLUSIVE: Modular Medical Transitions To Commercial Stage With Pivot Insulin Pump Launch | 2 | Benzinga.com |
1 2 3 4 Weiter >>
61 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEALWELL AI | 0,415 | +0,97 % | HEALWELL AI: HEALWELL AI Announces Voting Results of 2026 AGSM | Toronto, Ontario--(Newsfile Corp. - June 26, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative... ► Artikel lesen | |
| LIFEWARD | 7,100 | +1,72 % | Lifeward Ltd.: Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing | HUDSON, Mass. and YOKNEAM ILLIT, Israel, July 07, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio... ► Artikel lesen | |
| IMUNON | 1,240 | -0,80 % | Imunon, Inc.: IMUNON Reports Positive Phase 2 MRD Clinical Data for IMNN-001, Demonstrating the Successful Overcoming of Historical IL-12 Safety Barriers in Frontline Ovarian Cancer | Preliminary data reinforces IMNN-001 immunotherapy's potential for success in the rapidly recruiting Phase 3 OVATION 3 clinical trial Lower rate of minimal residual disease (MRD)Higher ctDNA clearance... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 43,400 | -2,69 % | Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Michael H. Carrel to its Board of Directors | MINNEAPOLIS, July 27, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP), a medical technology company focused on innovative, minimally invasive solutions for patients with obstructive... ► Artikel lesen | |
| INSPIREMD | 0,530 | +6,00 % | InspireMD, Inc. - 8-K, Current Report | ||
| GT BIOPHARMA | 0,306 | +1,52 % | GT Biopharma, Inc.: GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors | GTB-5550 is now the 3rd TriKE- to enter the clinic and an expansion into a broader solid tumor opportunity, with the Phase 1 trial likely to focus on prostate cancer patients during the dose escalation... ► Artikel lesen | |
| MYOMO | 0,794 | -3,17 % | MYOMO, INC. - 8-K, Current Report | ||
| INOGEN | 5,700 | +0,88 % | Inogen Inc - S-8, Securities to be offered to employees in employee benefit plans | ||
| INTELLIGENT BIO SOLUTIONS | 1,560 | +0,65 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry | Company has addressed final review items from penetration testing and finalized cybersecurity and software documentation 510(k) package submission on track for calendar H2 2026, targeting planned... ► Artikel lesen | |
| INCANNEX HEALTHCARE | 2,890 | -0,69 % | Incannex Healthcare: Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea | First clinical sites approved and actively screening potential participantsRepresents another major milestone in the advancement of IHL-42X towards Phase III developmentIHL-42X has received FDA Fast... ► Artikel lesen | |
| LEXARIA BIOSCIENCE | 0,530 | 0,00 % | Lexaria Bioscience Corp.: Lexaria Updates Business Development | KELOWNA, BC / ACCESS Newswire / July 6, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to have experienced many... ► Artikel lesen | |
| GLUCOTRACK | 0,290 | +1,75 % | Glucotrack, Inc. - 8-K, Current Report | ||
| LENSAR | 5,240 | -0,19 % | LENSAR, Inc.: LENSAR Reports First Quarter 2026 Results and Provides Business Update | 7 ALLY Robotic Cataract Laser Systems® ("ALLY System") Placements in First Quarter 2026; Backlog of 11 ALLY Systems as of March 31, 2026 First Quarter Recurring Revenue was $12.6 million Total Laser... ► Artikel lesen | |
| JIN MEDICAL INTERNATIONAL | 2,040 | +3,55 % | Jin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement | CHANGZHOU, China, April 7, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated... ► Artikel lesen | |
| MINIMED GROUP | 16,414 | +2,06 % | MiniMed appoints Alcon CEO David Endicott and Linnea Burman to its Board of Directors | David Endicott, Chief Executive Officer of Alcon, brings global healthcare leadership and public company experience; Linnea Burman adds MedTech operating depth NORTHRIDGE, Calif., June... ► Artikel lesen |
Das Unternehmen MODULAR MEDICAL INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,010 (-0,48 %) liegt der Kurs bei 2,070 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MODULAR MEDICAL INC finden Sie auf Wallstreet Online.